These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 1977702)
1. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [TBL] [Abstract][Full Text] [Related]
2. The current status of gastric prokinetic drugs. Schapira M; Henrion J; Heller FR Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914 [TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. McCallum RW; Fink SM; Lerner E; Berkowitz DM Gastroenterology; 1983 Jun; 84(6):1573-7. PubMed ID: 6132852 [TBL] [Abstract][Full Text] [Related]
4. Prokinetic therapy for gastroesophageal reflux disease. Robinson M Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432 [TBL] [Abstract][Full Text] [Related]
5. Prokinetic agents in postgastrectomy patients. Patterson DJ Gastroenterol Clin North Am; 1994 Jun; 23(2):313-25. PubMed ID: 7915253 [TBL] [Abstract][Full Text] [Related]
6. Drug therapy of reflux oesophagitis: an update. Tytgat GN Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792 [TBL] [Abstract][Full Text] [Related]
7. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622 [TBL] [Abstract][Full Text] [Related]
10. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Brown CK; Khanderia U Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745 [TBL] [Abstract][Full Text] [Related]
11. Review of the current status of prokinetic agents in gastroenterology. McCallum RW Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997 [No Abstract] [Full Text] [Related]
12. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related]
13. [Primperan and gastroesophageal reflux. Review of the literature]. Albot G Ann Gastroenterol Hepatol (Paris); 1985 May; 21(2 Pt 2):17-20. PubMed ID: 3898989 [TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal motility. Part I--The pathophysiologic approach to the management of reflux esophagitis. Holloway RH; Winnan G; McCallum RW Am J Gastroenterol; 1981 Sep; 76(3):280-90. PubMed ID: 6119024 [No Abstract] [Full Text] [Related]
15. [Gastroesophageal reflux in the newborn]. Urrusti-Sanz J Gac Med Mex; 1995; 131(5-6):601-3. PubMed ID: 8768609 [No Abstract] [Full Text] [Related]
16. [Prokinetics in reflux disease. Action mechanisms and clinical effects]. Hatlebakk JG; Berstad A Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients. McCallum RW; Kline MM; Curry N; Sturdevant RA Gastroenterology; 1975 May; 68(5 Pt 1):1114-8. PubMed ID: 1092585 [TBL] [Abstract][Full Text] [Related]
18. Prokinetic agents: a key in the future of gastroenterology. Reynolds JC Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178 [TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of gastrointestinal motility disorders]. Jia B Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932 [No Abstract] [Full Text] [Related]